1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine dihydrochloride → 2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1)

HRID 1012977

Reaktionsgleichung

Reaktionsgleichung von HRID 1012977
[ClH:1].Cl.[C:3]([C:5]1[CH:6]=[C:7]2[C:11](=[CH:12][CH:13]=1)[NH:10][CH:9]=[C:8]2[CH2:14][CH2:15][CH2:16][CH2:17][N:18]1[CH2:23][CH2:22][N:21]([C:24]2[CH:25]=[CH:26][C:27]3[O:31][C:30]([C:32](=[O:34])[NH2:33])=[CH:29][C:28]=3[CH:35]=2)[CH2:20][CH2:19]1)#[N:4]>O>[ClH:1].[C:3]([C:5]1[CH:6]=[C:7]2[C:11](=[CH:12][CH:13]=1)[NH:10][CH:9]=[C:8]2[CH2:14][CH2:15][CH2:16][CH2:17][N:18]1[CH2:19][CH2:20][N:21]([C:24]2[CH:25]=[CH:26][C:27]3[O:31][C:30]([C:32](=[O:34])[NH2:33])=[CH:29][C:28]=3[CH:35]=2)[CH2:22][CH2:23]1)#[N:4]

Komponenten

3

Versuchsvorschrift

10 g of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine dihydrochloride Form XIII are dispersed in 1 l water. After stirring for 48 hours the crystals are recovered by filtration, and drying in vacuo to constant weight at room temperature leads to 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride hydrate of Form V.

Aufarbeitung

  1. filtrationare recovered by filtration
  2. customdrying in vacuo to constant weight at room temperature

Quellen und Nachweise

ORD-Eintrag
ord-3d59947f3a904e0e8c337beb6b0aa655
Quelldatensatz
uspto-grants-2011_07
Patentnummer
US07981894B2

Verknüpfte Notizen

Wird geladen…